Scottish NHS declines Schering-Plough treatments
This article was originally published in Scrip
Executive Summary
Schering-Plough has had an unsuccessful start to the month at the hands of the Scottish Medicines Consortium (SMC), which has declined two submissions for use of the company's ulcerative colitis and progressive multiple myeloma treatments in the Scottish NHS.